Reports
Sale
Global Bio Implants Market Size, Share, Trends, Analysis: By Product: Autografts, Allografts, Xenografts; By Application: Cardiovascular Implants, Orthopedic Implants, Dental Implants, Spinal implants, Ophthalmic Implants, Other Soft Tissue Implants; By Material: Biomaterial Metal and Alloys, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Bio Implants Market Outlook
The global bio implants market size was valued at USD 122.8 billion in 2023, driven by the rising demand of implants in managing cardiovascular diseases and orthopedic disorders across the globe. The market is expected to grow at a CAGR of 9.56% during the forecast period of 2024-2032, with the values likely to rise from USD 134.2 billion in 2024 to USD 275.4 billion by 2032.
Global Bio Implants Market Overview
Biomedical implants or bio implants are medical devices injected or surgically implanted into the body to support, repair, replace, or enhance the existing biological structure. According to the World Health Organisation (WHO), chronic diseases account for 41 million deaths annually. The rising burden of chronic diseases is anticipated to bolster the market growth in the future. In addition, technical advancements such as advent of biocompatible materials, surge in research initiatives, as well as increasing application of bioimplants in multiple domains including cardiology, neurology and dentistry among others is projected to bolster the bio implants market growth in the forecast period.
In October 2023, Evonik introduced an innovative carbon-fiber reinforced PEEK filament to be used in 3D printing of medical implants. VESTAKEEP® filament featured 12% and 20% carbon fiber content, offering high strength, flexibility and ductility. Applied as 3D medical implants, it can be used in bone plates and other reconstructive prostheses. Growing utilisation of smart materials in developing compatible, lightweight, and durable implants in one of the most significant trends in the market, helping to curb the rising bio implants market demand.
In recent years, technical advancements and a better understanding of human anatomy has led to development of several innovative products. With surface engineering of bio-implants, the market has been flourished with sustainable implants. These not only help in expedited healing, but also provide solutions for a diverse range of consumers, including aging patients and those suffering from osteoporosis and diabetes. One such example is UV-treated bio implants, developed by a team of UCLA School of Dentistry researchers in November 2023. The ultraviolet light treated titanium implants are expected to hold a significant bio implants market share in coming years. It exhibits up to 60% bacterial susceptibility and highly accurate bone integration. It also reduces the risk of complications, side effects while promoting faster healing.
Other factors that impact the market dynamics consist of the growing adoption of bioimplants therapies in the healthcare sector, increased patient awareness, and improvements in the regulatory landscape. Moreover, emphasis on improving the healthcare infrastructure for enhanced patient experience also impact the market scenario positively.
Global Bio Implants Market Trends
| Key Trend | Impact |
| Technological Advancements | Due to the technological advancements occurring in the bio implant materials and manufacturing processes, the market has expanded significantly. The biocompatible material which can be integrated seamlessly with human tissue has revolutionized the field by reducing the risk of rejection and extending the lifespan of implants. |
| Growing Demand for Orthopedic Implants | The surge in demand for bio implants has increased due to the rise in musculoskeletal disorders like osteoporosis and arthritis, especially in the geriatric population. The implants are used to restore mobility in joint replacements, and therefore, improve quality of life for millions of people. With the growing geriatric population and increasing prevalence of orthopedic disorders, the bio implants market demand is estimated to elevate in the forecast period. |
| Increase in Cardiovascular Implants | The cardiovascular implants including stents, pacemakers, and structural cardiac implants are in demand as the global burden of cardiovascular diseases is increasing. The rise in lifestyle changes, aging population, and an increased prevalence of diabetes and hypertension results in cardiovascular diseases, hence, appropriate intervention is a key area of attention amongst researchers. |
| Expansion into Emerging Economies | The improving healthcare infrastructure, rising healthcare expenditures, and growing public awareness of advanced medical treatments have accelerated the expansion of the market share into emerging economies. |
Global Bio Implants Market Segmentation
Market Breakup by Product
- Autografts
- Allografts
- Xenografts
The market segmentation by product includes autografts, allografts, and xenografts. These products cater to specific clinical demands and patient needs, providing unique benefits. Autografts carry a lower risk of rejection and are primarily incorporated in dental, orthopedic or reconstruction surgeries. Allografts offer an advantage of tissue preservation. It is mostly used in cases of burn, skin grafting, and ligament repair. Xenografts carry a burden of ethical consideration as well as higher risk. One of the successful examples of xenografts in clinical settings is the porcine heart valve.
Market Breakup by Application
- Cardiovascular Implants
- Orthopedic Implants
- Dental Implants
- Spinal implants
- Ophthalmic Implants
- Other Soft Tissue Implants
The applications of bioimplants include cardiovascular, orthopedic, dental, spinal, and ophthalmic implants along with other soft tissues implants. The diverse application of bio implants is likely to boost its market share.
Market Breakup by Material
- Biomaterial Metal and Alloys
- Polymers
- Other Materials
By material, the bio implants market share is segmented into biomaterials metal and alloys, polymers, and other materials. Incorporating the right choice of material is crucial as it impacts the functionality and determines the long-term success of the implant. Improvements in existing material and development of new ones are driven by the requirement of efficient, biocompatible, and durable implants.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market report offers insights into major regional markets including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America leads the market segment which can be attributed to the presence of an advanced healthcare infrastructure along with heightened patient awareness which enables more people to seek bioimplant treatment options. Asia Pacific, on the other hand, is likely to witness expedited growth in the forecast period.
Global Bio Implants Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- aap Implantate AG
- Abbott Laboratories
- Bausch & Lomb Incorporated
- BIOTRONIK Inc.
- Edwards Lifesciences Corporation
- LifeNet Health
- MiMeDX
- Smith & Nephew PLC
- Zimmer Biomet
- Boston Scientific Corporation
- Stryker Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by Material |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Global Bio Implants Market Report
- How will the market landscape evolve in the forecast period?
- What future trends can be anticipated in the market?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which regional market is expected to experience expedited growth during the forecast period?
- Which product type will lead the market growth?
- Which type of bio implant material is expected to dominate the respective market segment?
- What are the key research initiatives expected to boost the market value during the forecast period?
- Which application area is poised to make the highest impact on the bio implants market growth?
- What is the market share, strategies, and product portfolios of the leading players in the market?
- How is the regulatory landscape shaping the market?
- What are the market dynamics, trends, and growth prospects in the key regional markets?
- How is technological innovation impacting the development of bioimplants?
- What are the investment opportunities and potential risks associated with the market?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Bio Implants Market Overview
3.1 Global Bio Implants Market Historical Value (2017-2023)
3.2 Global Bio Implants Market Forecast Value (2024-2032)
4 Global Bio Implants Market Landscape*
4.1 Global Bio Implants Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Bio Implants Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Platform
4.2.3 By Treatment Sample
5 Global Bio Implants Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Bio Implants Market Segmentation (2017-2032)
6.1 Global Bio Implants Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Autografts
6.1.3 Allografts
6.1.4 Xenografts
6.2 Global Bio Implants Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Cardiovascular Implants
6.2.3 Orthopedic Implants
6.2.4 Dental Implants
6.2.5 Spinal implants
6.2.6 Ophthalmic Implants
6.2.7 Other Soft Tissue Implants
6.3 Global Bio Implants Market (2017-2032) by Material
6.3.1 Market Overview
6.3.2 Biomaterial Metal and Alloys
6.3.3 Polymers
6.3.4 Other Materials
6.4 Global Bio Implants Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Bio Implants Market (2017-2032)
7.1 North America Bio Implants Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Autografts
7.1.3 Allografts
7.1.4 Xenografts
7.2 North America Bio Implants Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Cardiovascular Implants
7.2.3 Orthopedic Implants
7.2.4 Dental Implants
7.2.5 Spinal implants
7.2.6 Ophthalmic Implants
7.2.7 Other Soft Tissue Implants
7.3 North America Bio Implants Market (2017-2032) by Material
7.3.1 Market Overview
7.3.2 Biomaterial Metal and Alloys
7.3.3 Polymers
7.3.4 Other Materials
7.4 North America Bio Implants Market (2017-2032) by Country
7.4.1 United States of America
7.4.2 Canada
8 Europe Bio Implants Market (2017-2032)
8.1 Europe Bio Implants Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Autografts
8.1.3 Allografts
8.1.4 Xenografts
8.2 Europe Bio Implants Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Cardiovascular Implants
8.2.3 Orthopedic Implants
8.2.4 Dental Implants
8.2.5 Spinal implants
8.2.6 Ophthalmic Implants
8.2.7 Other Soft Tissue Implants
8.3 Europe Bio Implants Market (2017-2032) by Material
8.3.1 Market Overview
8.3.2 Biomaterial Metal and Alloys
8.3.3 Polymers
8.3.4 Other Materials
8.4 Europe Bio Implants Market (2017-2032) by Country
8.4.1 United Kingdom
8.4.2 Germany
8.4.3 France
8.4.4 Italy
8.4.5 Others
9 Asia Pacific Bio Implants Market (2017-2032)
9.1 Asia Pacific Bio Implants Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Autografts
9.1.3 Allografts
9.1.4 Xenografts
9.2 Asia Pacific Bio Implants Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Cardiovascular Implants
9.2.3 Orthopedic Implants
9.2.4 Dental Implants
9.2.5 Spinal implants
9.2.6 Ophthalmic Implants
9.2.7 Other Soft Tissue Implants
9.3 Asia Pacific Bio Implants Market (2017-2032) by Material
9.3.1 Market Overview
9.3.2 Biomaterial Metal and Alloys
9.3.3 Polymers
9.3.4 Other Materials
9.4 Asia Pacific Bio Implants Market (2017-2032) by Country
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 ASEAN
9.4.5 Australia
9.4.6 Others
10 Latin America Bio Implants Market (2017-2032)
10.1 Latin America Bio Implants Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Autografts
10.1.3 Allografts
10.1.4 Xenografts
10.2 Latin America Bio Implants Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Cardiovascular Implants
10.2.3 Orthopedic Implants
10.2.4 Dental Implants
10.2.5 Spinal implants
10.2.6 Ophthalmic Implants
10.2.7 Other Soft Tissue Implants
10.3 Latin America Bio Implants Market (2017-2032) by Material
10.3.1 Market Overview
10.3.2 Biomaterial Metal and Alloys
10.3.3 Polymers
10.3.4 Other Materials
10.4 Latin America Bio Implants Market (2017-2032) by Country
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Mexico
10.4.4 Others
11 Middle East and Africa Bio Implants Market (2017-2032)
11.1 Middle East and Africa Bio Implants Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Autografts
11.1.3 Allografts
11.1.4 Xenografts
11.2 Middle East and Africa Bio Implants Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Cardiovascular Implants
11.2.3 Orthopedic Implants
11.2.4 Dental Implants
11.2.5 Spinal implants
11.2.6 Ophthalmic Implants
11.2.7 Other Soft Tissue Implants
11.3 Middle East and Africa Bio Implants Market (2017-2032) by Material
11.3.1 Market Overview
11.3.2 Biomaterial Metal and Alloys
11.3.3 Polymers
11.3.4 Other Materials
11.4 Middle East and Africa Bio Implants Market (2017-2032) by Country
11.4.1 Saudi Arabia
11.4.2 United Arab Emirates
11.4.3 Nigeria
11.4.4 South Africa
11.4.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 aap Implantate AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bausch & Lomb Incorporated
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 BIOTRONIK Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Edwards Lifesciences Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 LifeNet Health
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 MiMeDX
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Smith & Nephew PLC
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Zimmer Biomet
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Boston Scientific Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Stryker Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Bio Implants Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total Market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 122.8 billion in 2023 driven by the rising demand of implants in managing cardiovascular diseases and orthopedic disorders across the globe.
The market is anticipated to grow at a CAGR of 9.56% during the forecast period of 2024-2032, likely to reach a market value of USD 275.4 billion by 2032.
Heightened patient awareness and increased healthcare expenditure are fuelling the demand for the market.
The increasing application of smart materials in developing bio implants is one of the significant market trends. For instance, in November 2023, UCLA School of Dentistry researchers developed ultraviolet (UV) light treated titanium implants, which exhibit up to 60% bacterial susceptibility while reducing the risk of complications.
Based on the product, the market is segmented into autografts, allografts, and xenografts.
Materials used in developing bioimplants include biomaterials metal and alloys, and polymers, among others.
Application areas of bioimplants include cardiovascular, orthopedic, dental, spinal, ophthalmic, and other soft tissue implants.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are aap Implantate AG, Abbott Laboratories, Bausch & Lomb Incorporated, BIOTRONIK Inc., Edwards Lifesciences Corporation, LifeNet Health, MiMeDX, Smith & Nephew PLC, Zimmer Biomet., Boston Scientific Corporation, and Stryker Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER